Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BOLT stock hub

Bolt Biotherapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOLTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

BOLT

In the news

Latest news · BOLT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-79.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-32.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOLT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

199

Groups with data

Currency

USD

Showing 199 of 199 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001641281
Company name	Bolt Biotherapeutics, Inc.
Country	United States
Country code	US
Cusip	097702203
Employees	23
Employees Change	-29%
Employees Change Percent	-55.77
Enterprise value	$4.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-02-05
Isin	US0977022039
Last refreshed	2026-05-10
Market cap	$9M
Market cap category	Nano-Cap
Price	$4.78
Price currency	USD
Rev Per Employee	334,565.22x
Sector	Healthcare
Sic	2834
Symbol	BOLT
Website	https://www.boltbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-371.93%
EV Sales Forward	0.72x
EV/Sales	0.58x
FCF yield	-444.88%
P/B ratio	0.34x
P/S ratio	1.17x
PS Forward	1.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-270.8%
Gross Profit	$-20.8M
Net Income	$-33.4M
Net Income Growth Quarters	3%
Net Income Growth Years	4%
Pretax Margin	-433.74%
Profit Per Employee	$-1.5M
ROA	-27.68
Roa5y	-27.79
ROCE	-71.68
ROE	-79.75
Roe5y	-63.21
ROIC	-32.83

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-32.69%
Cagr3y	-47.04%
Cagr5y	-59.83%
EPS Growth Quarters	3
EPS Growth Years	5
Revenue Growth	0.07x
Revenue Growth Years	1x
Revenue Growth3 Y	10.33x
Revenue Growth5 Y	101.61x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.1
Assets	$56.7M
Cash	$27.5M
Current Assets	$30.3M
Current Liabilities	$8.4M
Debt	$23M
Debt Equity	$0.87
Equity	$26.5M
Liabilities	$30.2M
Long Term Assets	$26.5M
Long Term Liabilities	$21.8M
Net Cash	$4.5M
Net Cash By Market Cap	$50.67
Net Cash Growth	-79.44%
Net Debt Equity	$-0.17
Tangible Book Value	$26.5M
Tangible Book Value Per Share	$13.8
WACC	2.89

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.59
Net Working Capital	$-2.9M
Quick ratio	3.38
Working Capital	$21.8M
Working Capital Turnover	$0.27

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.06%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-32.68%
200-day SMA	5.25
3Y total return	-85.16%
50-day SMA	4.59
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.95%
All Time High	861.4
All Time High Change	-99.45%
All Time High Date	2021-03-11
All Time Low	3.91
All Time Low Change	22.25%
All Time Low Date	2026-03-13
ATR	0.42
Beta	1.1
Beta1y	0.04
Beta2y	0.41
Ch YTD	-12.58
High	5.19
High52	9.25
High52 Date	2025-05-21
High52ch	-48.31%
Low	4.66
Low52	3.91
Low52 Date	2026-03-13
Low52ch	22.25%
Ma50ch	4.05%
Price vs 200-day SMA	-8.95%
RSI	47.82
RSI Monthly	27.44
RSI Weekly	44.56
Sharpe ratio	-0.27x
Sortino ratio	-0.32
Total Return	2.06%
Tr YTD	-12.58
Tr1w	-5.53%
Tr3m	-17.16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	2
Analyst Price Target Top	$13.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-3.45
Earnings Revenue Estimate	1,500,000x
Earnings Revenue Estimate Growth	22.75x
Operating Income	$-34.6M
Operating margin	-450.1
Price target	$34
Price Target Change	$611
Price Target Change Top	$182

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,771,395%
Float Percent	92.18%
Shares Insiders	0.65%
Shares Institutions	22.39%
Shares Out	1,921,567
Shares Qo Q	-10.01%
Shares Yo Y	-2.06%
Short Float	1.28%
Short Ratio	1.16
Short Shares	1.18

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-42.7M
Average Volume	27,722.65x
Bv Per Share	13.8
CAPEX	$-72,000
Ch1w	-5.53
Ch1y	-32.68
Ch3m	-17.16
Ch3y	-85.16
Ch5y	-98.95
Ch6m	5.06
Change	4.14%
Change From Open	2.58
Close	4.59
Days Gap	1.53
Depreciation Amortization	1,291,000
Dollar Volume	191,252.6
Earnings Date	2026-05-13
Earnings Time	amc
EBIT	$-34.6M
EBITDA	$-33.3M
EPS	$-17.85
F Score	3
FCF	$-39.9M
FCF EV Yield	-901.84x
FCF Per Share	$-20.78
Financing CF	19,000
Fiscal Year End	December
Founded	2,015
Investing CF	44,302,000
Ipr	-76.1
Iprfo	-99.08
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-12
Last Report Date	2025-12-31
Last Split Date	2025-06-09
Last Split Type	Reverse
Last10k Filing Date	2026-03-12
Ma150	5.2
Ma150ch	-8.08%
Ma20	4.85
Ma20ch	-1.42%
Net CF	4,471,000
Next Earnings Date	2026-05-22
Open	4.66
Optionable	No
Position In Range	22.64
Post Close	4.78
Postmarket Change Percent	-2.3
Postmarket Price	$4.67
Ppne	20,475,000
Price Date	2026-05-08
Ptbv Ratio	0.34
Relative Volume	1.44x
Revenue	7,695,000x
SBC By Revenue	36.15x
Share Based Comp	2,782,000
Tr6m	5.06%
Us State	California
Volume	40,011
Z Score	-12.53

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOLT pay a dividend?

Capital-return profile for this ticker.

Performance

BOLT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOLT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+22.4%

Float: +92.2% of shares outstanding

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BOLT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.8

Neutral momentum band

Price vs 200-day MA

-9.0%

50/200-day relationship not available

Beta (5Y)

1.10

Moves roughly with the market

Sharpe ratio

-0.27

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOLT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BOLT stock rating?

Bolt Biotherapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BOLT analysis?

The full report lives at /stocks/BOLT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BOLT?

The latest report frames BOLT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BOLT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.